<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present study is a second analysis of a randomized double-blind controlled trial on the efficacy of neurotropin on <z:hpo ids='HP_0002181'>brain edema</z:hpo> in a subgroup of patients with <z:hpo ids='HP_0011009'>acute</z:hpo> middle cerebral artery <z:mpath ids='MPATH_124'>infarct</z:mpath> treated within 24 hours </plain></SENT>
<SENT sid="1" pm="."><plain>Neurotropin is a biological extract that specifically inhibits the release of bradykinin </plain></SENT>
<SENT sid="2" pm="."><plain>The mortality rate was significantly lower in the neurotropin than in the placebo group </plain></SENT>
<SENT sid="3" pm="."><plain>In the surviving patients the neurological deficit decreased to a significantly greater extent by neurotropin therapy after 15 days </plain></SENT>
<SENT sid="4" pm="."><plain>The CT scan findings in the brain of the neurotropin-treated patients demonstrated a significant reduction in the size of the <z:mpath ids='MPATH_124'>infarct</z:mpath> and of the edematous area </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with middle cerebral artery <z:mpath ids='MPATH_124'>infarct</z:mpath>, which is prone to give rise to fatal intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo>, may derive great benefit from treatment of <z:hpo ids='HP_0002181'>brain edema</z:hpo> with neurotropin </plain></SENT>
</text></document>